urti
benign
selflimit
syndrom
typic
last
day
manifest
rhinorrhea
cough
fever
caus
multipl
famili
virus
pathogen
frequent
associ
common
cold
symptom
rhinovirus
case
coronavirus
respiratori
syncyti
viru
influenza
virus
parainfluenza
virus
adenovirus
also
caus
common
cold
symptom
lesser
degre
direct
contact
smallparticl
aerosol
largeparticl
aerosol
spread
common
cold
virus
persontoperson
contact
depend
amount
time
peopl
spend
togeth
amount
viru
shed
infect
donor
rel
close
commun
secondari
attack
rate
rang
handtohand
contact
import
factor
transmiss
diseas
effici
mean
viral
transmiss
spread
infecti
mucoid
secret
finger
hand
subsequ
nose
eye
suscept
person
virus
viabl
human
skin
least
hour
one
studi
found
certain
virus
could
recov
hand
person
cold
eas
transmiss
demonstr
need
encourag
proper
hand
wash
athlet
popul
import
prevent
measur
reduc
number
ill
time
away
sport
common
cold
seriou
complic
acut
bacteri
sinus
develop
adult
patient
viral
urti
infect
also
complic
lower
respiratori
tract
diseas
pneumonia
link
acut
asthma
attack
adult
import
sport
medicin
physician
readili
identifi
common
symptom
properli
diagnos
effect
manag
viral
urti
reduc
seriou
complic
ill
viral
urti
difficult
distinguish
less
common
bacteri
case
sole
base
clinic
examin
find
physic
examin
light
subject
discomfort
patient
symptom
may
vari
patient
patient
ill
incub
period
common
cold
virus
hour
cold
usual
persist
day
normal
host
howev
cold
may
last
long
week
risk
factor
increas
sever
diseas
includ
young
age
low
birth
weight
prematur
chronic
diseas
immunodefici
disord
malnutrit
crowd
antivir
therapi
avail
virus
caus
viral
urti
therefor
despit
standard
confirm
viral
cultur
rare
indic
uncompl
urti
outpati
set
patient
viral
urti
increas
white
blood
cell
count
associ
left
shift
viral
infect
precipit
atyp
lympocyt
lymphocytosi
lymphopenia
howev
complet
blood
count
help
distinguish
diseas
direct
therapi
uncompl
urti
outpati
set
evid
antibiot
clinic
import
effect
cold
uncompl
secondari
infect
symptomat
therapi
remain
foundat
common
cold
treatment
number
agent
studi
demonstr
vari
effect
cours
ill
tabl
level
consist
goodqual
patientori
evid
sort
evid
rate
system
b
level
b
inconsist
limitedqu
patientori
evid
sort
evid
rate
system
accord
american
colleg
sport
medicin
athlet
common
cold
symptom
without
fever
gener
bodi
ach
pain
intens
exercis
train
may
safe
resum
day
resolut
symptom
mildtomoder
exercis
appear
harm
individu
common
cold
symptom
set
appropri
supervis
athlet
viral
urti
fever
myalgia
symptom
neck
safe
continu
previou
level
activ
restrict
returntoplay
decis
made
casebycas
basi
focu
minim
risk
harm
sinus
one
common
ill
diagnos
unit
state
affect
adult
popul
annual
sinus
defin
inflamm
one
paranas
sinus
categor
acut
week
subacut
week
chronic
week
caus
sinus
viral
bacteri
tabl
viral
infect
common
caus
acut
sinus
usual
resolv
day
acut
bacteri
sinus
also
usual
selflimit
diseas
case
resolv
without
treatment
month
left
untreat
howev
bacteri
sinus
may
spontan
resolv
sever
complic
includ
intracrani
orbit
infect
diagnosi
sinus
base
combin
clinic
histori
physic
examin
find
imag
studi
laboratori
test
assist
diagnosi
chronic
complic
case
symptom
acut
sinus
includ
nasal
congest
purul
nasal
discharg
maxillari
tooth
discomfort
headach
fever
facial
pain
pressur
wors
lean
forward
unfortun
histori
sensit
specif
distinguish
viral
bacteri
infect
although
symptom
sinus
nonspecif
histori
persist
purul
rhinorrhea
facial
pain
appear
correl
increas
likelihood
bacteri
diseas
physic
examin
includ
palpat
sinus
transillumin
visual
nare
assist
differenti
bacteri
viral
sinus
frequent
sinus
present
facial
tender
affect
sinu
caviti
transillumin
report
opaqu
transmiss
dull
reduc
transmiss
normal
sensit
specif
techniqu
poor
one
prospect
studi
found
abnorm
transillumin
combin
purul
nasal
discharg
histori
maxillari
pain
poor
respons
decongest
color
rhinorrea
best
predictor
acut
bacteri
sinus
sinu
aspir
cultur
gold
standard
make
microbi
diagnosi
done
routin
clinic
practic
sinu
aspir
consid
suspicion
intracrani
extens
infect
seriou
complic
imag
studi
usual
indic
noncompl
case
bacteri
sinus
provid
confirmatori
evid
clinic
diseas
persist
despit
optim
medic
therapi
ct
scan
usual
procedur
choic
provid
better
sensit
plain
radiograph
versu
unfortun
neither
test
distinguish
bacteri
viral
infect
ct
scan
limit
fact
frequent
abnorm
patient
common
cold
one
studi
adult
viral
cold
abnorm
ct
sinus
includ
occlus
abnorm
sinu
caviti
addit
mri
use
detect
intracrani
spread
infect
distinguish
inflammatori
diseas
malign
tumor
evalu
fungal
diseas
howev
mri
good
ct
scan
diagnos
acut
sinus
symptomat
treatment
mainstay
treatment
viral
sinus
antibiot
gener
benefici
convers
antibiot
benefici
medic
treatment
acut
bacteri
sinus
patient
acut
sinu
infect
antibiot
recommend
symptom
improv
day
sever
ill
symptom
worsen
day
appropri
choic
antibiot
base
like
bacteri
pathogen
clinic
histori
current
literatur
support
amoxicillin
initi
antibiot
choic
children
adult
uncompl
bacteri
sinus
cours
antibiot
typic
success
treatment
acut
bacteri
sinus
symptomat
treatment
includ
antihistamin
decongest
nasal
steroid
may
benefici
treatment
viral
bacteri
sinus
despit
use
treat
symptom
antihistamin
prove
benefici
recommend
recent
guidelin
diagnosi
manag
sinus
children
decongest
decreas
nasal
resist
may
benefici
manag
acut
sinus
howev
rel
littl
systemat
studi
decongest
patient
sinus
intranas
steroid
also
commonli
use
treatment
sinus
evid
use
intranas
steroid
acut
bacteri
sinus
use
recommend
acut
viral
sinus
selflimit
ill
symptom
usual
resolv
day
exercis
may
permit
appropri
symptomat
care
particularli
symptom
remain
neck
nasal
congest
facial
pain
headach
forth
athlet
present
sever
symptom
howev
includ
fever
myalgia
vigor
exercis
avoid
prevent
dehydr
worsen
symptom
athlet
symptom
worsen
day
persist
longer
day
appropri
antibiot
treatment
initi
particip
allow
toler
acut
pharyng
account
million
clinic
visit
annual
relat
ambulatori
visit
unit
state
acut
pharyng
caus
viral
bacteri
pathogen
viral
caus
account
approxim
acut
pharyng
infect
caus
pharyng
indistinguish
bacteri
pharyng
viral
agent
includ
influenza
viru
parainfluenza
viru
coronaviru
rhinoviru
adenoviru
enteroviru
herp
simplex
viru
epsteinbarr
viru
ebv
hiv
potenti
complic
major
treatabl
pathogen
group
streptococcu
ga
account
adult
case
bacteri
pathogen
includ
group
c
group
g
streptococcu
mix
anaerob
neisseria
gonorrhoea
corynebacterium
diptheria
sever
chlamydi
speci
even
though
differenti
diagnosi
acut
pharyng
adult
includ
sever
viral
bacteri
pathogen
risk
rheumat
fever
acut
glomerulonephr
support
complic
minim
effici
accur
diagnosi
treatment
ga
pharyng
appropri
treatment
import
differenti
viral
caus
bacteri
caus
especi
ga
viral
pharyng
associ
clinic
find
includ
pharyng
swell
erythema
exud
furthermor
presenc
cough
suggest
viral
etiolog
primari
herp
simplex
viru
infect
may
also
associ
palat
vesicl
shallow
ulcer
bacteri
pharyng
difficult
distinguish
viral
pharyng
clinic
howev
constel
symptom
use
suggest
ga
infect
includ
erythema
swell
exud
tonsil
pharynx
fever
f
higher
tender
anterior
cervic
lymph
node
absenc
conjunct
cough
rhinorrhea
scarlet
rash
may
seen
ga
infect
particularli
patient
younger
year
appear
tini
papul
chest
abdomen
often
describ
sandpaperlik
rash
spread
becom
erythemat
groin
armpit
usual
resolv
within
day
laboratori
evalu
assist
clinician
identifi
ga
infect
throat
cultur
remain
gold
standard
diagnos
ga
pharyng
may
isol
pathogen
proper
techniqu
sensit
throat
cultur
approach
specif
rang
fals
posit
result
link
carrier
rate
organ
cultur
take
hour
grow
immedi
use
clinic
decis
whether
start
antibiot
therefor
rapid
streptococc
antigen
test
rsat
emerg
first
test
choic
manag
acut
pharyng
studi
show
sensit
specif
although
less
sensit
throat
cultur
rsat
provid
result
minut
assist
sameday
manag
symptomat
care
alon
appropri
acut
pharyng
case
major
except
ga
pharyng
requir
appropri
antibiot
treatment
prevent
potenti
complic
minim
secondari
spread
shorten
cours
ill
tabl
athlet
sexual
activ
clinician
may
need
consid
gonococc
infect
caus
acut
pharyng
gonococc
infect
easili
treatabl
proper
antibiot
found
nonsteroid
antiinflammatori
drug
nsaid
reduc
sore
throat
symptom
hour
less
day
compar
placebo
caution
must
advis
prescrib
nsaid
howev
associ
gastrointestin
renal
advers
effect
studi
children
adolesc
moder
sever
sore
throat
without
group
beta
hemolyt
ga
infect
shown
oral
dexamethason
reduc
time
initi
pain
relief
durat
throat
pain
compar
placebo
ad
corticosteroid
antibiot
howev
significantli
reduc
pain
durat
children
adolesc
group
beta
hemolyt
ga
infect
athlet
suspect
confirm
acut
bacteri
pharyng
import
rememb
consid
contagi
antibiot
therapi
hour
recommend
particip
time
pass
treat
appropri
individu
see
improv
acut
symptom
within
hour
may
progress
activ
toler
close
supervis
remov
competit
often
unnecessari
athlet
fever
system
symptom
infecti
mononucleosi
mono
common
ill
young
adult
includ
athlet
popul
mono
occur
colleg
popul
character
triad
fever
tonsillar
pharyng
lymphadenopathi
long
accept
ebv
infecti
pathogen
mono
ebv
wide
dissemin
herpesviru
spread
intim
contact
suscept
host
asymptomat
ebv
shedder
often
call
kiss
diseas
ebv
primarili
spread
way
passag
saliva
viru
persist
oropharynx
patient
histori
mono
month
clinic
recoveri
often
ill
go
undiagnos
symptom
mild
adolesc
young
adult
develop
symptom
higher
frequenc
rang
although
mono
gener
benign
ill
splenic
ruptur
known
seriou
complic
mono
estim
occurr
case
per
almost
report
case
occur
male
patient
occas
splenic
ruptur
first
present
symptom
mono
spontan
half
report
case
histori
impact
incit
injuri
vital
returntoplay
decis
splenic
ruptur
occur
primarili
fourth
day
symptomat
ill
despit
potenti
life
threaten
fatal
splenic
ruptur
rare
classic
mono
present
moder
high
fever
pharyng
lymphadenopathi
one
studi
patient
demonstr
lymphadenopathi
occur
fever
occur
pharyng
occur
document
case
posterior
cervic
lymph
node
characterist
involv
anterior
chain
mono
node
may
larg
moder
tender
lymphadenopathi
peak
first
week
gradual
resolv
week
pharyng
mono
commonli
describ
exud
may
appear
white
graygreen
display
necrot
featur
find
includ
sever
fatigu
splenomegali
studi
divis
collegi
athlet
mean
splenic
size
cm
length
cm
wide
seven
percent
athlet
baselin
spleen
size
met
current
criteria
splenomegali
popul
singl
ultrasound
evalu
spleen
size
limit
valu
clinic
judgment
may
use
splenomegali
associ
mono
occur
patient
usual
reced
third
week
ill
laboratori
inform
import
confirm
diagnosi
mono
peripher
blood
smear
commonli
show
white
blood
cell
count
differenti
show
lymphocyt
atyp
contrast
find
atyp
lympocyt
heterophil
antibodi
sensit
specif
mono
respect
heterophil
antibodi
blank
entri
recommend
level
consist
goodqual
patientori
evid
sort
evid
rate
system
b
level
b
inconsist
limitedqu
patientori
evid
sort
evid
rate
system
c
level
c
recommend
base
consensu
usual
practic
opinion
diseaseori
evid
case
seri
studi
diagnosi
treatment
prevent
screen
appear
within
week
onset
clinic
symptom
peak
week
may
persist
low
level
month
measur
ebvspecif
antibodi
often
obtain
lieu
heterophil
antibodi
athlet
determin
acuiti
ill
mainstay
treatment
patient
mono
support
care
treatment
returntoplay
decis
make
gear
toward
reduc
probabl
splenic
ruptur
acetaminophen
nsaid
recommend
treatment
fever
pharyng
malais
import
stress
adequ
fluid
nutrit
intak
adequ
rest
necessari
strict
bed
rest
warrant
corticosteroid
antivir
therapi
studi
treatment
mono
multicent
placebocontrol
trial
patient
acut
mono
combin
acyclovir
prednisolon
reduc
oropharyg
shed
viru
affect
durat
symptom
lead
earlier
return
school
work
metaanalysi
five
random
control
trial
acyclovir
treatment
acut
mono
fail
show
clinic
benefit
compar
placebo
athlet
mono
need
special
attent
strict
guidelin
return
play
individu
avoid
splenic
ruptur
athlet
particip
sport
activ
acut
ill
mono
sport
medicin
physician
recal
spontan
traumat
splenic
ruptur
set
mono
usual
occur
within
fourth
day
onset
clinic
symptom
athlet
may
return
easi
graduat
train
week
spleen
palpabl
enlarg
pain
athlet
afebril
pharyng
complic
resolv
liver
enzym
grossli
abnorm
athlet
may
return
contact
sport
vigor
train
recondit
necessari
week
four
condit
met
urti
common
acut
ill
particularli
athlet
increas
risk
transmiss
popul
urti
manag
take
account
type
ill
potenti
complic
ill
demand
place
athlet
particip
practic
competit
sport
medicin
physician
arm
latest
evid
accur
diagnos
properli
treat
acut
urti
ill
athlet
overtreat
urti
antibiot
especi
indic
lead
antibiot
resist
returntoplay
decis
made
casebycas
basi
athlet
take
account
overal
safeti
athlet
teammat
coach
staff
expos
athlet
sport
medicin
physician
repres
first
line
defens
prevent
diagnos
manag
acut
urti
athlet
ensur
safe
return
athlet
competit
